Clinical TrialsSearch results
Number of results: 282
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Other
- A Phase I/II Study of Vinorelbine plus Trastuzumab in Patients with Advanced/Recurrent Breast Cancer Previously Treated with Anthracyclines and Taxanes
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2006-07-13
Other
- Capecitabine/cyclophosphamide combination therapy for patients with advanced or metastatic breast cancer who have been previously treated with anthracyclines - a phase 2 study
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2005-07-07
Other
- Feasibility study of adjuvant chemotherapy consisting of FEC(fluoraouracil, epirubicin and cyclophosphamide) followed by DH(docetaxel+herceptin) for patients with HER2 positive breast cancer
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17
Other
- Feasibility study of TC(docetaxel+Cyclophosphamide)as adjuvant chemotherapy for intermediate risk primary breast cancer with HER2-negative and ER-positive tumor(KBC-SG 0803)
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17
Other
- Phase II study of sequential administration of FEC (Fluorouracil / Epirubicin / Cyclophosphamide) followed by Docetaxel as adjuvant chemotherapy for node-positive breast cancer
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2006-04-06
Other
- Evaluation of the steroid ointment utility to prevent the injection site reactions and phlebitis caused by vinorelbine.
- cancer
- Nagasaki Thoracic Oncology Group
- 2012-12-31
Other
- Outreach palliative care Trial of integrated regional model
- Cancer
- Outreach Palliative care Trial of Integrated regional Model OPTIM study project
- 2008-07-31
Other
- Optimal combination of pharmacological agents for cardiovascular and renal complications of diabetes mellitus and impaired glucose tolerance
- Cardiovascular and renal complications of diabetes mellitus and impaired glucose tolerance
- Kyoto Medical Centar
- 2009-04-01
Other
- Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
- CD20 positive diffuse large B cell lmyphoma
- Japan Clinical Oncology Group(JCOG)
- 2007-12-04